U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 4,650.00
-160.00 (-3.33%)
At close: Feb 5, 2026
U2Bio Revenue
U2Bio had revenue of 6.87B KRW in the quarter ending September 30, 2025, with 6.81% growth. This brings the company's revenue in the last twelve months to 25.59B, down -2.62% year-over-year. In the year 2024, U2Bio had annual revenue of 25.04B, down -18.68%.
Revenue (ttm)
25.59B
Revenue Growth
-2.62%
P/S Ratio
2.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
60.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.04B | -5.75B | -18.68% |
| Dec 31, 2023 | 30.79B | -38.22B | -55.38% |
| Dec 31, 2022 | 69.01B | 58.01B | 527.29% |
| Dec 31, 2014 | 11.00B | 1.59B | 16.90% |
| Dec 31, 2013 | 9.41B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seojin Automotive | 2.87T |
| Keum Kang Steel | 192.97B |
| eSang Networks Co.,Ltd | 112.26B |
| ASFLOW Co., LTD. | 75.76B |
| HYULIM A-TECH | 36.87B |
| Bi Matrix | 31.60B |
| TS Trillion | 27.95B |
| Suprema HQ | 21.19B |